Karrington Clinical Laboratory has acquired Matrix Clinical Laboratory from Matrix Medical Network. The sale is part of the strategy Matrix Medical Network announced in 2022 to refocus its portfolio of services on in-home health and care assessments. Terms of the deal were not disclosed.
Karrington will focus on the continued growth of the lab, develop new and improved molecular diagnostic testing and laboratory processes, and expand its testing menu using its minimally invasive phlebotomy technology.
Matrix Clinical Laboratory is a CLIA-certified and CAP-accredited laboratory delivering clinical diagnostic tests.
According to data captured in the LevinPro HC database, this is the first Laboratories, MRI and Dialysis transaction of 2023. There were 132 deals reported in the sector in 2022.
